Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berry

Showing results (211-220 of 343) with videos related to

Pageof 35
Sort By:
European Journal of Biochemistry|October 15, 1994
The capacity of reducing-equivalent shuttles limits glycolysis during ethanol oxidationM N Berry, R B Gregory, A R Grivell, et al.
Journal of Health Politics, Policy and Law|August 13, 2017
Litigation Provides Clues to Ongoing Challenges in Implementing Insurance ParityKelsey N Berry, Haiden A Huskamp, Howard H Goldman, et al.
Journal of Human Virology|April 9, 1999
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infectionN Berry, K Ariyoshi, S Jaffar, et al.
American Journal of Medical Genetics|December 1, 1993
Najjar syndrome revisitedI T Thomas, T Jewett, P Lantz, et al.
British Journal of Cancer|February 1, 1985
The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancerN Berry, D B Jones, J Smallwood, et al.
Thrombosis and Haemostasis|January 1, 1996
Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombinC Lunven, C Gauffeny, C Lecoffre, et al.
The Journal of Hospital Infection|October 12, 2004
An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unitS Majumdar, A Kirby, N Berry, et al.
British Journal of Pharmacology|June 1, 1996
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparinN Duval, C Lunven, D P O'Brien, et al.
Alcoholism, Clinical and Experimental Research|March 27, 2013
Mifepristone pretreatment reduces ethanol withdrawal severity in vivoLynda Sharrett-Field, Tracy R Butler, Jennifer N Berry, et al.
Current Therapeutic Research, Clinical and Experimental|May 1, 1975
Acetaminophen extra strength capsules versus propoxphene compound-65 versus placebo: a double-blind study of effectiveness and safetyM T Smith, H M Levin, W W Bare, et al.
Pageof 35

Showing results (211-220 of 343) with videos related to

Sort By:
Pageof 35
European Journal of Biochemistry|October 15, 1994
The capacity of reducing-equivalent shuttles limits glycolysis during ethanol oxidationM N Berry, R B Gregory, A R Grivell, et al.
Journal of Health Politics, Policy and Law|August 13, 2017
Litigation Provides Clues to Ongoing Challenges in Implementing Insurance ParityKelsey N Berry, Haiden A Huskamp, Howard H Goldman, et al.
Journal of Human Virology|April 9, 1999
Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infectionN Berry, K Ariyoshi, S Jaffar, et al.
American Journal of Medical Genetics|December 1, 1993
Najjar syndrome revisitedI T Thomas, T Jewett, P Lantz, et al.
British Journal of Cancer|February 1, 1985
The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancerN Berry, D B Jones, J Smallwood, et al.
Thrombosis and Haemostasis|January 1, 1996
Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombinC Lunven, C Gauffeny, C Lecoffre, et al.
The Journal of Hospital Infection|October 12, 2004
An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unitS Majumdar, A Kirby, N Berry, et al.
British Journal of Pharmacology|June 1, 1996
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparinN Duval, C Lunven, D P O'Brien, et al.
Alcoholism, Clinical and Experimental Research|March 27, 2013
Mifepristone pretreatment reduces ethanol withdrawal severity in vivoLynda Sharrett-Field, Tracy R Butler, Jennifer N Berry, et al.
Current Therapeutic Research, Clinical and Experimental|May 1, 1975
Acetaminophen extra strength capsules versus propoxphene compound-65 versus placebo: a double-blind study of effectiveness and safetyM T Smith, H M Levin, W W Bare, et al.
Pageof 35